Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Titel:
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Auteur:
Prat, Aleix Saura, Cristina Pascual, Tomás Hernando, Cristina Muñoz, Montserrat Paré, Laia González Farré, Blanca Fernández, Pedro L Galván, Patricia Chic, Núria González Farré, Xavier Oliveira, Mafalda Gil-Gil, Miguel Arumi, Miriam Ferrer, Neus Montaño, Alvaro Izarzugaza, Yann Llombart-Cussac, Antonio Bratos, Raquel González Santiago, Santiago Martínez, Eduardo Hoyos, Sergio Rojas, Beatriz Virizuela, Juan Antonio Ortega, Vanesa López, Rafael Céliz, Pamela Ciruelos, Eva Villagrasa, Patricia Gavilá, Joaquín